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BACKGROUND: Coronary artery disease (CAD) is one of the leading causes of death in Malaysia. However, 
the prevalence of CAD in males is higher than in females and mortality rates are also different between the 
two genders. This suggest that risk factors associated with mortality between males and females are differ-
ent, so we compared the clinical characteristics and outcome between male and female STEMI patients. 
OBJECTIVES: To identify the risk factors associated with mortality for each gender and compare differences, 
if any, among ST-elevation myocardial infarction (STEMI) patients. 
DESIGN: Retrospective analysis.
SETTINGS: Hospitals across Malaysia.
PATIENTS AND METHODS: We analyzed data on all STEMI patients in the National Cardiovascular 
Database-Acute coronary syndrome (NCVD-ACS) registry for the years 2006 to 2013 (8 years). We collected 
demographic and risk factor data (diabetes mellitus, hypertension, smoking status, dyslipidaemia and fam-
ily history of CAD). Significant variables from the univariate analysis were further analysed by a multivariate 
logistic analysis to identify risk factors and compare by gender. 
MAIN OUTCOME MEASURES: Differential risk factors for each gender.
RESULTS: For the 19 484 patients included in the analysis, the mortality rate over the 8 years was significantly 
higher in females (15.4%) than males (7.5%) (P<.001). The univariate analysis showed that the majority of male 
patients <65 years while females were ≥65 years. The most prevalent risk factors for male patients were smok-
ing (79.3%), followed by hypertension (54.9%) and diabetes mellitus (40.4%), while the most prevalent risk 
factors for female patients were hypertension (76.8%), followed by diabetes mellitus (60%) and dyslipidaemia 
(38.1%). The final model for male STEMI patients had seven significant variables: Killip class, age group, hy-
pertension, renal disease, percutaneous coronary intervention and family history of CVD. For female STEMI 
patients, the significant variables were renal disease, smoking status, Killip class and age group.
CONCLUSION: Gender differences existed in the baseline characteristics, associated risk factors, clinical 
presentation and outcomes among STEMI patients. For STEMI females, the rate of mortality was twice that 
of males. Once they reach menopausal age, when there is less protection from the estrogen hormone and 
there are other risk factors, menopausal females are at increased risk for STEMI. 
LIMITATION: Retrospective registry data with inter-hospital variation.
Coronary artery disease (CAD) is the number one cause of mortality and morbidity in Malaysia and globally for both males and females.1,2 
Even worse, CAD has remained the principal cause of 
death for the ten years from 2005 to 2014.3 In CAD, 
which is also known as ischemic heart disease, a waxy 
substance called plaque builds up inside the coronary 
arteries.4
CAD, traditionally considered a male disease, is also 
a major threat to females nowadays. In general, females 
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with CAD have a worse outcome than their male coun-
terparts when no adjustments are made for other char-
acteristics and comorbidities.5,6 Although females tend 
to present with CAD later in life, the outcome can be 
severe.6 Even when they present young, they tend to 
receive less evidence-based treatment than their male 
counterparts.7
An ongoing prospective registry known as the 
Malaysian National Cardiovascular Disease-Acute 
Coronary Syndrome (NCVD-ACS) registry was first es-
tablished in 2006. Starting with only 8 hospitals in 2006, 
it now includes 18 hospitals across the country. The reg-
istry was introduced to collect clinical data including in-
hospital management and clinical outcome. The Ministry 
of Health Malaysia has become the main sponsor of the 
NCVD-ACS Registry with National Heart Association of 
Malaysia as the co-sponsor.8 Technical support in the 
form of clinical epidemiology expertise, biostatistics and 
information and communication technology services are 
provided by the Clinical Research Centre of Malaysia. 
The database is a useful source of information such as 
demographic values of patients as well as medical infor-
mation, which are helpful in understanding the trends of 
CAD among the Malaysian population.
In one way or another, CAD affects all Malaysians. 
Most adults at increased risk of CAD have no symptoms 
or obvious signs, especially females, but they may be 
identified by assessment of risk factors. Therefore, the 
main aim of the study was to identify the risk factors 
associated with mortality for each gender and com-
pare differences, if any, among acute coronary disease 
patients, particularly ST-elevation myocardial infarction 
(STEMI) patients.
PATIENTS AND METHODS
Anonymised patient data were obtained from the 
NCVD-ACS registry for the 8-year period from the years 
2006 to 2013. The registry enrols patients presenting 
with STEMI, non-ST elevation myocardial infarction 
(NSTEMI), and unstable angina (UA). However, in this 
study, only the data of patients who were diagnosed with 
STEMI from 18 participating hospitals across Malaysia 
were selected from the NCVD-ACS registry. Among the 
different types of acute coronary syndrome, STEMI has 
the worst outcome.1 In this setting, STEMI was defined 
as persistent ST segment elevation ≥1 mm in two con-
tiguous electrocardiographic leads, or the presence of a 
new left bundle branch block in the setting of positive 
cardiac markers.9 
Data was collected from the time the patient with 
STEMI was admitted to the hospital until discharge. 
Each patient was assigned a unique national identifica-
tion number to avoid duplication. Follow-up was done 
30 days after hospital discharge via phone call or when 
the patient came to the clinic for a review. To verify the 
mortality status, a cross check was done with the na-
tional death registry. Patient characteristics and clinical 
presentation, in-hospital treatment and clinical outcome 
were recorded. After verification, data was then entered 
into the NCVD website. An extensive information and 
communications technology system is maintained to en-
sure functional efficacy and effectiveness in the NCVD 
operation. 
In addition to gender, other demographic variables 
such as ethnicity and age group are available. The 
ethnicity was determined based on national identity 
cards and self-report. In this study, patients were cat-
egorised into two age groups based on local medical 
practice namely age <65 years and age ≥65 years.9 The 
risk factors were diabetes mellitus, hypertension, smok-
ing status, dyslipidaemia and family history of CAD. 
Comorbid variables included myocardial infarction (MI) 
history, chronic lung disease, cerebrovascular disease, 
peripheral vascular disease and renal disease. Clinical 
presentation known as Killip class was divided into four 
classes. The Killip classification predicts the odds of sur-
vival within 30 days in patients with an acute MI, with 
a higher class having a higher odds of dying whereby 
Killip IV is the highest class.10 Treatment variables were 
percutaneous coronary intervention (PCI) and cardiac 
catheterisation. This NCVD registry study was approved 
by the Medical Review & Ethics Committee, Ministry of 
Health Malaysia in 2007 (Approval Code: NMRR-07-20-
250). MREC waived informed consent for NCVD.
Results are presented in the form of descriptive sta-
tistics, followed by univariate analysis and a multivari-
ate logistic regression model. Categorical variables are 
described as percentages. Chi-square tests were used 
to test the association between factors by gender. 
Stepwise logistic regression was used to explain the 
relationships of all independent variables to mortality. 
A P value of less than .05 was considered statistically 
significant. A Hosmer and Lemeshow test was used to 
determine the goodness of fit. The variable inflation fac-
tor test is a test of multicollinearity. The -2log-likelihood 
is used to measure how well the model actually fits the 
data and the change in fit of the model to data if a vari-
able is removed or added to the model. All analyses 
were conducted using SPSS statistical software (version 
22, IBM SPSS Statistics, Armonk, NY, USA).
RESULTS
For females, the mortality rate (15.4%) was significantly 
higher than for males (7.5%) (P<.001) over the 8-year 
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Characteristics Female(n=2811)
Male
(n=16673)  P value
Demographic Ethnicity Malay 1540 (54.8) 9887 (59.3) <.001
Chinese 523 (18.6) 2984 (17.9)
Indian 595 (21.2) 2718 (16.3)
Others 152 (5.4) 1084 (6.5)
Age group <65 1465 (52.1) 13488 (80.9) <.001
≥65 1346 (47.9) 3185 (19.1)
Risk factor Diabetes mellitus Yes 1687 (60.0) 6736 (40.4) <.001
Hypertension Yes 2159 (76.8) 9153 (54.9) <.001
Smoking status Active/former 309 (11.0) 13221 (79.3) <.001
Dyslipidaemia Yes 1071 (38.1) 5836 (35.0) <.007
Family history of CAD Yes 304 (10.8) 2684 (16.1) <.001
Comorbidities MI history Yes 315 (11.2) 2284 (13.7) <.001
Chronic lung disease Yes 62 (2.2)       417 (2.5)      .472
Cerebrovascular 
disease Yes 135 (4.8) 467 (2.8) <.001
Peripheral vascular 
disease Yes 11 (0.4) 50 (0.3) .444
Renal disease Yes 183 (6.5)       584 (3.5)       <.001
Class I 1574 (56.9) 10737 (64.4)
Clinical 
presentation Killip class Class II 677 (24.1) 3501 (21.0) <.001
Class III 180 (6.4) 717 (4.3)
Class IV 351 (12.5) 1717(10.3)
Treatment PCI Yes 697 (24.8) 5019 (30.1) <.001
Cardiac catheterization Yes 807 (28.7) 5736 (34.4) <.001
Table 1.  Demographic and clinical characteristics  by gender for 19 484 patients from the  National Cardiovascular 
Database-Acute coronary syndrome registry for the years 2006 to 2013.
period. Nevertheless, the percentage of female pa-
tients affected with STEMI (14.4%) was fewer than 
males (85.6%). The patient population was mainly eth-
nic Malay (more than 50.0% for both male and female 
patients) (Table 1). The majority of male patients were 
≤65 years while females were mostly ≥65 years. For fe-
males ≥65 years, the incidence of CAD was twice that 
of males. The most prevalent risk factors for male pa-
tients were smoking (79.3%), followed by hypertension 
(54.9%) and diabetes mellitus (40.4%), while the most 
prevalent risk factors for female patients were hyperten-
sion (76.8%), followed by diabetes mellitus (60%) and 
dyslipidaemia (38.1%). MI history was the most com-
mon comorbidity followed by renal disease and cere-
brovascular disease for both male and female patients. 
The majority of the STEMI patients were in Killip class I 
or II on presentation. As part of their continuing medi-
cal care, cardiac catheterization was the most frequent 
procedure followed by PCI for both male and female 
patients. All variables showed a statistically signifi-
cant difference between males and females except for 
chronic lung disease (P=.472) and peripheral vascular 
disease (P=.444). 
In the univariate analysis, all variables were sig-
nificant for males (data not shown). Among the most 
significant were Killip class (odds ratio (OR=15.9), age 
group (OR=3.2) and renal disease (OR=3.9) for male 
patients. In the multivariate model for males (Table 2), 
seven variables were significant: diabetes mellitus, hy-
pertension, family history of CAD, renal disease, PCI, 
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Table 2.  Variables in the regression model for male patients.
Variable Characteristic b Standard error P value Adjusted odds ratio (95% CI)
Diabetes 
mellitus No Reference
Yes 0.294 0.107 .006 1.342 (1.088, 1.655)
Hypertension No Reference
Yes 0.479 0.113 <.001 1.615 (1.295, 2.014)
Family history 
of CAD No Reference
Yes -0.373 0.171 .029 0.689 (0.493, 0.963)
Renal disease No Reference
Yes 0.858 0.198 <.001 2.358 (1.598,3.478)
Killip 
classification Class I Reference
Class II 0.720 0.143 <.001 2.054 (1.553, 2.717)
Class III 2.208 0.167 <.001 9.095 (6.556, 12.617)
Class IV 2.792 0.128 <.001 16.314 (12.685,20.981)
PCI No Reference
Yes -0.359 0.114 .002 0.698 (0.558, 0.873)
Age group <65 Reference
≥65 0.861 0.110 <.001 2.365 (1.905, 2.935)
-2 log-likelihood: 2803.447, Hosmer and Lemeshow P=.202
Killip class and age group. The adjusted odds ratio sug-
gests that patients with diabetes mellitus are 1.3 times 
more likely to die than those who are not diabetic. Also, 
male patients with hypertension and renal disease have 
1.6 and 2.3 times respectively higher mortality risk than 
those without it, whereas, patients with a family history 
of CAD are less likely to die (OR=0.7). The regression 
coefficients, for all Killip class are significant, indicating 
that increasing affluence is associated with an increased 
odds of death. Also, Killip class IV are 16.5 times more 
likely to die than Killip class I males (base category). 
Moreover, the risk of mortality is 2.4 times higher for 
male patients from the age group ≥65 than from the 
age group <65. The mortality of patients who had un-
dergone PCI were significantly less with an OR of 0.69 
as compared to those without PCI. 
In the univariate analysis on females, all variables 
were also significant. Among the highest were Killip 
class (OR=12.8), renal disease (OR=2.6) and age group 
(OR=2.5). The best-fitting multivariate model for fe-
males is given in Table 3. Of the 15 variables, only 4 
were statistically significant in the multivariate model: 
smoking, renal disease, Killip class and age group. The 
adjusted odds ratio suggests that females who smoked 
are less likely to die (OR=0.49), while the mortality of 
female patients is 2.2 times higher with renal disease 
than those without renal failure. The effect of Killip class 
in the model is also significant, indicating that those 
with Killip class IV are 14.6 times more likely to die than 
those from Killip class I. Equally important is the age 
group where the risk of mortality is 3.4 times higher 
in female patients from the age group ≥65 years than 
those from the age group <65 years. 
The -2log-likelihood values obtained by comparing 
the final model with the null model with no covariates, 
showed a significant decrease in the -2log-likelihood. 
Likewise, the Hosmer and Lemeshow tests of the good-
ness of fit found that both final models fit well to the 
data as the P values were greater than .05. The degree 
of accuracy of both models was 93.3% and 87.5%. Also, 
the variable inflation factor test indicates an absence 
of multicollinearity in the variables for both males and 
females.
DISCUSSION
CAD is the leading cause of mortality among both males 
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Table 3. Variables in the regression model for female patients.
Variable Characteristic b Standard error P value Adjusted odds ratio (95% CI)
Smoking status Never Reference
Active/former -0.793 0.352 .024 0.453 (0.227, 0.903)
Renal disease No Reference
Yes 0.663 0.338 .049 1.941 (1.002, 3.762)
Killip 
classification Class I Reference
Class II .860 0.235 <.001 2.364 (1.491, 3.750)
Class III 1.482 0.336 <.001 4.403 (2.278, 8.511)
Class IV 2.720 0.235 <.001 15.183 (9.572, 24.081)
Age group <65 Reference
≥65 1.003 0.190 <.001 2.727 (1.878, 3.961)
-2 log-likelihood: 800.099, Hosmer and Lemeshow P value=.393
and females in Malaysia. With cancer, tuberculosis, HIV/
AIDS, and malaria combined, CAD is still the most com-
mon cause of mortality in females worldwide, killing 
more than 16 per minute.11 That the percentage of fe-
males affected with STEMI was much lower than males 
is supported by other studies where STEMI is more 
prevalent among males as compared to females.9,12,13 
However, females had a significantly higher mortality 
rate as compared to male patients in our study, which 
is compatible with other findings indicating that females 
have had higher mortality rates than males annually since 
1984 with the cause of death mostly from myocardial in-
farction and sudden death.14,15 Females are more resil-
ient to developing CAD, but once they have CAD, they 
are more likely to experience the worse consequences.16 
Contrary to popular belief, CAD, and not breast cancer, is 
the main cause of death in women, where there is a two 
to one ratio of CAD between males and females.17 Also, 
females are twice as likely to die of a first MI and notably 
have a short-term survival as compared with males.18,19 
In addition, since females have smaller coronary vessels 
than males, females are twice as likely to die as a result 
from coronary artery bypass surgery.18,20
The motivation of this study was to assess whether 
gender differences exist in risk factors, clinical presenta-
tion and outcomes among STEMI patients in Malaysia. 
This study found that in females aged 65 years and 
older, the incidence of STEMI is twice of males. This is 
similar to previous studies which found that larger risk 
of acute MI and a significantly higher mortality rate in 
female patients aged 65 years and older.21,22 Female risk 
climbs as they age and once females reach menopausal 
age, there is less protection from the estrogen hormone 
and together with other risk factors like diabetes mellitus 
and obesity, menopausal women are at greater risks for 
CAD.21,23 Moreover, due to the misconception that acute 
coronary syndrome is a disease of men; most women 
lack the awareness and are considered more at risk for 
breast cancer than for CAD.18 Contrary to men, atypical 
symptoms such as numbness of the arms, fatigue, nau-
sea, jaw pain, tightness or pressure, but no pain over the 
left chest are often present among women with CAD.18,20 
Physicians often fail to distinguish these symptoms in 
women.24
Smoking is the most prevalent risk factor for males 
(79.3%) followed by hypertension (54.9%) and diabe-
tes mellitus (40.4%). This is supported by the National 
Health and Morbidity Survey Malaysia which stated that 
the Malaysian population has a higher prevalence of 
smoking with the prevalence of adult male smokers be-
ing 46.5%.25,26 This is consistent with the NCVD database 
registry annual reports.12 Moreover, a high prevalence of 
smoking (48.7%) and hypertension (31.7%) among male 
residents in rural Selangor, Malaysia were found in an-
other study.27 Even though most of the disease burden 
caused by active smoking occurs among males, females 
bear nearly 80% of the total burden from passive smok-
ing.28 In this context, passive smoking is the inhalation of 
smoke, called second-hand smoke, or environmental to-
bacco smoke, by persons other than the intended active 
smoker.29 The number of deaths among females caused 
by passive smoking is about two-thirds of that caused by 
smoking for CAD and lung cancer.28 Also, another study 
stated that passive smoking wives of current or former 
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cigarette smokers had a higher death rate from isch-
emic heart disease than women whose husbands never 
smoked.30
From the multivariate logistic model, smoking is 
one the significant variables in females. The odds ratio 
suggests that females who smoke are less likely to die 
(OR=0.49). This surprising outcome is similar to a previ-
ous study whereby active smokers have a tendency to 
do well at both in-hospital and 30-days post discharge 
with significantly lesser overall mortality risk compared 
to those who never smoked.25 Another study suggested 
that even though most of the females who die of CAD 
are past menopausal age, smoking increases the dan-
ger in younger females than in older females.31 In addi-
tion, women are less likely to quit smoking than men.32 
In this study, the most prevalent risk factors for females 
were hypertension (76.8%) followed by diabetes mel-
litus (60%) and dyslipidaemia (38.1%). A study of the 
NCVD-ACS registry patients between 2006 and 2008 
reported that out of 9702 patients, 24.2% were females 
with 22.3% being menopausal women, which was asso-
ciated with diabetes mellitus and hypertension.33
The findings of the present study for both males and 
females are supported by a preceding study whereby 
on admission, more than 95% of patients having not 
less than one common cardiovascular risk factor such 
as hypertension, smoking, dyslipidaemia and diabetes 
mellitus.12 Diabetes mellitus has been well recognized 
in increasing the risk of CAD in both males and fe-
males.34-37 A study on the numerous aspects of gender 
differences among 10 554 PCI patients in the NCVD-
PCI registry between 2007 to 2009 found that at pre-
sentation, women typically were five years older than 
men and had a higher prevalence of risk factors.5 Even 
more, the in-hospital and six-month mortality were also 
higher in women.5 Another study found that among 
13 591 patients in the NCVD-ACS registry from 2006 to 
2010, 24.2% were women and they had more risk fac-
tors, were not likely to undergo invasive treatment, and 
had a higher mortality.38 Besides, a review of autopsy 
reports done at the University Malaya Medical Centre 
from year 1996 to 2005 found that 83 of 936 female 
deaths were because of cardiac causes.39 Hypertension, 
diabetes mellitus and age were the most significant risk 
factors.
Apart from that, renal disease has become one of 
the significant findings for both males and females in 
this study. The mortalities of both male and female pa-
tients were twice as high with renal disease than those 
without it. Another study found that in patients with 
acute decompensated heart failure, one-year wors-
ening of renal function is a common comorbidity and 
strong predictor of all-cause and cardiovascular mor-
tality.40 As for clinical presentation, male and female 
patients with Killip class IV were 16.5 and 14.6 times, 
respectively, more likely to die than patients with Killip 
class I. This is supported by a previous study where the 
mortality rate within Killip classes were in descending 
order from class IV to III, II and I.16 Apart from that, a 
family history of CAD is one of the significant variables 
among males in this study. This is similar to the another 
study where a family history of CAD was a significant 
risk factor among patients of ABO blood groups with 
the majority of patients being males (57.4%).41
PCI, also known as coronary angioplasty, is a typi-
cal treatment for CAD. In this study, PCI is one of the 
significant variables in the multivariate logistic model 
for males. Patients who had undergone PCI had a lower 
mortality rate than those who had not undergone a 
PCI (OR=0.7). Therefore, PCI is considered an effective 
treatment in reducing morbidity and mortality. Primary 
PCI is the preferred treatment due to a better result.9,42,43 
Moreover, there were mortality advantages gained 
from PCI treatment for elderly patients even though the 
outcome of elderly patients after PCI is not as good as 
that of non-elderly patients.9 In another study, the lack 
of PCI treatment in acute MI patients has contributed 
to the high in-hospital mortality among female patients 
with 12.3% as compared to 9.5% for males.44 To over-
come this problem, the Malaysian Ministry of Health, 
together with the Ministry of Education and National 
Heart Institute, initiated a better Kuala Lumpur STEMI 
network in 2015. This network plays an important role 
in referring acute STEMI patients between government 
hospitals, teaching university hospitals and the National 
Heart Institute right to PCI capable centres.13
In conclusion, gender differences existed in the 
baseline characteristics, associated risk factors, clini-
cal presentation and outcomes among STEMI pa-
tients. Female patients were older and more likely to 
have hypertension and diabetes mellitus, yet less likely 
to smoke than male patients. It is obvious that even 
though females share the same risk factors as males, 
there are risk factors that relate only to females which 
may increase their tendency to develop CAD. To date, 
with the enhancement of health care in general and the 
cardiac care specialist, understanding possible gender-
based differences in baseline characteristics, risk fac-
tors, treatments and outcomes will help in improving 
current management of females with CAD particularly 
STEMI. 
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